Prima Biomed's primary product CVAC is targetting Ovarian Cancer not Cervical Cancer.
It has spent years developing/pioneering the delivery method.
These guys in the UK would need to spend years to sort out the delivery method. Extensive retesting during trials and would also need the drug tested for off-label usage.
They are 5+ years away from anything.
AIMHO
Prima Biomed's primary product CVAC is targetting Ovarian Cancer...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $413.9M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 28.0¢ | $181.8K | 635.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 243656 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 99281 | 7 |
View Market Depth
| Last trade - 10.35am 04/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |